Inventiva Pharma (Global Rights to Odiparcil) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Inventiva Pharma (Global Rights to Odiparcil) General Information

Description

Global rights to Odiparcil.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Daix
  • France
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Daix
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inventiva Pharma (Global Rights to Odiparcil) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Inventiva Pharma (Global Rights to Odiparcil)‘s full profile, request access.

Request a free trial

Inventiva Pharma (Global Rights to Odiparcil) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Inventiva Pharma (Global Rights to Odiparcil)‘s full profile, request access.

Request a free trial

Inventiva Pharma (Global Rights to Odiparcil) FAQs

  • Where is Inventiva Pharma (Global Rights to Odiparcil) headquartered?

    Inventiva Pharma (Global Rights to Odiparcil) is headquartered in Daix, France.

  • What industry is Inventiva Pharma (Global Rights to Odiparcil) in?

    Inventiva Pharma (Global Rights to Odiparcil)’s primary industry is Buildings and Property.

  • Is Inventiva Pharma (Global Rights to Odiparcil) a private or public company?

    Inventiva Pharma (Global Rights to Odiparcil) is a Private company.

  • What is the current valuation of Inventiva Pharma (Global Rights to Odiparcil)?

    The current valuation of Inventiva Pharma (Global Rights to Odiparcil) is .

  • What is Inventiva Pharma (Global Rights to Odiparcil)’s current revenue?

    The current revenue for Inventiva Pharma (Global Rights to Odiparcil) is .

  • Who are Inventiva Pharma (Global Rights to Odiparcil)’s investors?

    Inventiva (Drug Discovery) has invested in Inventiva Pharma (Global Rights to Odiparcil).

  • When was Inventiva Pharma (Global Rights to Odiparcil) acquired?

    Inventiva Pharma (Global Rights to Odiparcil) was acquired on 01-Jan-2025.

  • Who acquired Inventiva Pharma (Global Rights to Odiparcil)?

    Inventiva Pharma (Global Rights to Odiparcil) was acquired by Biossil.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process